Elevating New Product Pricing Risk to the CEOs Strategic Agenda

The CEO's portfolio agenda must include new product pricing without credible experience because these products represent the enterprise's riskiest capital allocation—capital deployed against pricing assumptions that are based on judgment rather than data—and the CEO must personally govern the decision to allocate, maintain, increase, or withdraw that capital. The CUO and the CFO manage the new product's underwriting and financial performance, but the CEO owns the strategic decision: is the enterprise's capital being deployed to an innovation that will generate a return, or to an experiment whose assumptions are not being validated by the emerging experience? For CEOs, the new-product agenda item is the governance mechanism that ensures the enterprise's most uncertain capital allocation receives the CEO's direct oversight.

Why does the CEO's governance of new products matter more now?

The CEO's governance matters more now because the reinsurance market is demanding innovation—cyber, parametric, climate-risk products—and the CEO who does not personally govern the innovation risk is delegating the enterprise's riskiest capital decisions to a level below the CEO's visibility. The enterprise risk framework requires the CEO to govern the portfolio's most material risks.

The second reason is the board's expectation that the CEO governs innovation risk: the board will ask the CEO about the new products, their capital allocation, their performance, and the governance framework. A CEO who cannot answer is not governing the portfolio's innovation. The ten forces reshaping reinsurance include innovation governance as a CEO-level capability.

The third reason is the strategic decision that only the CEO can make: whether to continue investing in a new product whose early experience is ambiguous—not clearly validating and not clearly rejecting the pricing assumptions. The CUO and CFO can present the data; the CEO must make the judgment.

What goes wrong when the CEO does not include new products on the agenda?

When the CEO does not include new products: the capital allocation grows without CEO oversight, the governance framework is not defined, the performance monitoring is delegated, the exit decision is delayed, and the CEO discovers the exposure when the losses accumulate.

Put new product pricing on your CEO agenda—govern the innovation that determines your portfolio's future

Talk to Our Specialists

What do CEOs actually need from the new-product governance?

CEOs need a separate new-product agenda item, defined capital limits, monthly performance data, and a structured decision framework.

Rahul is the CEO of a reinsurer developing cyber products. He added a standing new-product review to his monthly portfolio agenda: the CUO presents the performance, the CFO presents the capital consumed, and Rahul decides whether to maintain, increase, or reduce the allocation. The governance framework gives Rahul direct oversight of the enterprise's riskiest capital.

• A standing new-product agenda item on the CEO's monthly portfolio review.
• A capital-allocation limit for each new product, approved by the CEO.
• Monthly performance data from the CUO and CFO.
• A structured decision framework: maintain, increase, reduce, or exit.
• A board-level new-product report presented by the CEO.
• A direct line of accountability from the CEO to the CUO for new-product governance.
• An annual review of the new-product portfolio strategy by the CEO.
• A communication to the board on the CEO's governance of innovation risk.

Conclusion

For CEOs, new product pricing without credible experience is a governance requirement, and the CEO who includes new products on the portfolio agenda governs the enterprise's riskiest capital allocation directly.

Frequently asked questions

Why must the CEO's portfolio agenda include new product pricing?

Because new products represent the riskiest capital allocation, and the CEO must personally govern the decision.

What is the CEO's role?

Approve capital, set the governance framework, review performance, and decide to maintain, increase, or withdraw.

How does the CEO govern new-product risk alongside the rest of the portfolio?

As a separate agenda item with its own limits, monitoring, and exit criteria.

What question should the CEO ask?

What is the maximum capital at risk, what are the withdrawal conditions, and how frequently is the experience monitored?

How does the CEO's governance affect innovation culture?

By governing the risk, the CEO creates space for innovation within a defined framework.

What is the consequence of the CEO not including new products on the agenda?

Capital expands beyond tolerance, and the CEO discovers the exposure when losses accumulate.

How should the CEO present new-product governance to the board?

As a separate agenda item with capital allocation, performance, governance framework, and the CEO's assessment.

What strategic decision must the CEO make?

Whether the emerging experience supports continued investment, and whether the pricing assumptions are being validated.

About the author

Hitul Mistry is the Founder of Insurnest, an InsurTech company that engineers end-to-end technology exclusively for the insurance industry serving carriers, TPAs, MGAs, brokers, and reinsurers across India, the UAE, and the US. With more than a decade of insurance domain experience, he has built systems spanning underwriting automation, AI-powered underwriting intelligence, claims management, rating and quoting, broking and agency platforms, and reinsurance automation across Health/GMC, Group Life, Motor, P&C, and Reinsurance. Insurnest doesn't adapt generic software to insurance; it builds from the workflow up.

Connect with Hitul on LinkedIn.